Elevation Oncology (NASDAQ:ELEV – Free Report) and Adverum Biotechnologies (NASDAQ:ADVM – Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, profitability and institutional ownership. Risk and Volatility Elevation Oncology has a beta of […]
Elevation Oncology (NASDAQ:ELEV – Free Report) and Adverum Biotechnologies (NASDAQ:ADVM – Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations and institutional ownership. Analyst Recommendations This is a breakdown of current recommendations […]
Elevation Oncology, Inc. (NASDAQ:ELEV – Get Rating) saw a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 2,570,000 shares, an increase of 596.3% from the May 15th total of 369,100 shares. Approximately 16.4% of the company’s stock are short sold. Based on an average […]
Tang Capital Management LLC acquired a new stake in Elevation Oncology, Inc. (NASDAQ:ELEV – Get Rating) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 479,854 shares of the company’s stock, valued at approximately $456,000. Tang Capital Management LLC […]
Elevation Oncology Announces Pricing of $50 Million Public Offering streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.